These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12723978)

  • 1. B cells as a therapeutic target in autoimmune disease.
    Goronzy JJ; Weyand CM
    Arthritis Res Ther; 2003; 5(3):131-5. PubMed ID: 12723978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases.
    Pers YM; Jorgensen C
    Immunotherapy; 2016 Sep; 8(9):1091-6. PubMed ID: 27485081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders.
    Edwards JC; Leandro MJ; Cambridge G
    Biochem Soc Trans; 2002 Aug; 30(4):824-8. PubMed ID: 12196207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does B cell depletion therapy work, and how can it be improved?
    Clark EA; Ledbetter JA
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv77-80. PubMed ID: 16239394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological therapies directed against cells in autoimmune disease.
    Hasler P
    Springer Semin Immunopathol; 2006 Jun; 27(4):443-56. PubMed ID: 16738955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rehabilitation or the death penalty: autoimmune B cells in the dock.
    Dahal LN; Cragg MS
    Eur J Immunol; 2015 Mar; 45(3):687-91. PubMed ID: 25639261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic functions of B cells in autoimmune diseases: IFN-γ production joins the criminal gang.
    Fillatreau S
    Eur J Immunol; 2015 Apr; 45(4):966-70. PubMed ID: 25727209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis.
    Dörner T; Isenberg D; Jayne D; Wiendl H; Zillikens D; Burmester G;
    Autoimmun Rev; 2009 Dec; 9(2):82-9. PubMed ID: 19716441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting B cells in treatment of autoimmunity.
    Franks SE; Getahun A; Hogarth PM; Cambier JC
    Curr Opin Immunol; 2016 Dec; 43():39-45. PubMed ID: 27718447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating human autoimmune disease by depleting B cells.
    Looney RJ
    Ann Rheum Dis; 2002 Oct; 61(10):863-6. PubMed ID: 12228152
    [No Abstract]   [Full Text] [Related]  

  • 12. B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks?
    Stohl W; Looney RJ
    Clin Immunol; 2006 Oct; 121(1):1-12. PubMed ID: 16697258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell reductive therapy in the treatment of autoimmune diseases: a focus on monoclonal antibody treatment of rheumatoid arthritis.
    Tuscano JM; Martin S; Song K; Wun T
    Hematology; 2005 Dec; 10(6):521-7. PubMed ID: 16321818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
    Guzman Moreno R
    Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell: a logical target for treatment of rheumatoid arthritis.
    Youinou P; Jamin C; Saraux A
    Clin Exp Rheumatol; 2007; 25(2):318-28. PubMed ID: 17543163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
    Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
    J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
    Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
    Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for B-cell-targeted therapy in autoimmune disease.
    Edwards JC; Cambridge G
    Rheumatology (Oxford); 2005 Feb; 44(2):151-6. PubMed ID: 15509628
    [No Abstract]   [Full Text] [Related]  

  • 19. B cell immunobiology in disease: evolving concepts from the clinic.
    Martin F; Chan AC
    Annu Rev Immunol; 2006; 24():467-96. PubMed ID: 16551256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.